Bioventus Inc. (BVS) Misses Q1 EPS by 11c

Bioventus Inc. (NASDAQ: BVS) reported Q1 EPS of ($0.26), $0.11 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $119.06 million versus the consensus estimate of $116.58 million.

For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.

You May Also Be Interested In

• CrowdStrike shares jump on earnings beat, raised outlook
• Inhibrx Biosciences (INBX) Reiterated at Market Perform by Citizens as Ozekibart Ph1 Started
• Ooma (OOMA) Tops Q2 EPS by 2c; offers guidance